Antibiotics 2021

5 papers
The 2021 edition of the journal Antibiotics featured research primarily focused on population pharmacokinetics (PK) and dose optimization for antimicrobial agents in specialized clinical settings. Much of the work addressed the challenges of dosing in critically ill patients, including those undergoing continuous veno-venous hemofiltration (CVVH) or exhibiting augmented renal clearance. Specific studies investigated the PK/PD profiles of vancomycin and ceftazidime to improve target attainment against infections such as Pseudomonas aeruginosa. Beyond clinical dosing, the research extended into veterinary medicine and predictive modeling. Work included the exploration of clinical breakpoints for danofloxacin against Glaesserella parasuis and the development of a Grey-BP neural network combination model to forecast resistance trends in animal-derived drugs. Prolific contributors to this year's output included researchers such as Chuhui Wang, Na He, and Suodi Zhai. These studies collectively emphasize the application of mathematical modeling and pharmacokinetic analysis to refine antibiotic efficacy and monitor resistance patterns across both human and animal health sectors.

Top Research Directions

The 10 research directions with Antibiotics 2021 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.

#Direction20212020Share 2021Share 20202020 rank
1Overcoming Pharmacokinetic Variability in Disease and Critical Illness3060.0%0.0%—
2Countering the Molecular Mechanisms of Antibiotic Resistance1120.0%100.0%1
3Hybrid Statistical and Neural Time Series Forecasting1020.0%0.0%—
4Mitigating Spatial Aggregation Bias in Public Health1020.0%0.0%—
5Overcoming Pathogen Spectrum Limitations in Antimicrobial Design1020.0%0.0%—
6Precision Dosing for Narrow Therapeutic Index Drugs1020.0%0.0%—
7Quantifying Resistance via Minimum Inhibitory Concentrations1020.0%0.0%—
8Reconstructing Continuous Paths from Sparse Temporal Observations1020.0%0.0%—
9Saturation and Adaptation in Nonlinear Pharmacokinetics1020.0%0.0%—
10The Descriptive Comparative Correlational Framework1020.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Antibiotics 2021 papers: a paper credits every institution named in its affiliations, once. 13 institutions share 5 credited papers.

#InstitutionPapersShare20202020 rank
1013e4n276 240.0%0—
2Capital Medical University 240.0%0—
3Peking University 240.0%0—
4Peking University Third Hospital 240.0%0—
500bcn1057 120.0%0—
6017px4740 120.0%0—
704grrp271 120.0%0—
805c9qnd49 120.0%0—
9China Agricultural University 120.0%0—
10Huazhong Agricultural University 120.0%0—
11Maastricht University Medical Centre 120.0%0—
12University of Amsterdam 120.0%0—
13Vrije Universiteit Amsterdam 120.0%0—

Download all institutions as CSV

About this data

Papers. Antibiotics 2021 lists 5 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 1 to 5 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 5 of 5 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Antibiotics 2021”, https://lacuna.tiptreesystems.com/venue/antibiotics/2021.

Papers

Title
A Prediction Method for Animal-Derived Drug Resistance Trend Using a Grey-BP Neural Network Combination Model
Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection